These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Dejardin E; Droin NM; Delhase M; Haas E; Cao Y; Makris C; Li ZW; Karin M; Ware CF; Green DR Immunity; 2002 Oct; 17(4):525-35. PubMed ID: 12387745 [TBL] [Abstract][Full Text] [Related]
25. Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction. Maracle CX; Agca R; Helder B; Meeuwsen JAL; Niessen HWM; Biessen EAL; de Winther MPJ; de Jager SCA; Nurmohamed MT; Tas SW Atherosclerosis; 2018 Mar; 270():33-41. PubMed ID: 29407886 [TBL] [Abstract][Full Text] [Related]
26. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096 [TBL] [Abstract][Full Text] [Related]
27. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway. Al-Sadi R; Guo S; Ye D; Rawat M; Ma TY Am J Pathol; 2016 May; 186(5):1151-65. PubMed ID: 26948423 [TBL] [Abstract][Full Text] [Related]
33. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Ramakrishnan P; Wang W; Wallach D Immunity; 2004 Oct; 21(4):477-89. PubMed ID: 15485626 [TBL] [Abstract][Full Text] [Related]
35. Classical and alternative NF-κB signaling cooperate in regulating adipocyte differentiation and function. Weidemann A; Lovas A; Rauch A; Andreas N; von Maltzahn J; Riemann M; Weih F Int J Obes (Lond); 2016 Mar; 40(3):452-9. PubMed ID: 26403432 [TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002 [TBL] [Abstract][Full Text] [Related]
37. A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB. Liu Z; Mar KB; Hanners NW; Perelman SS; Kanchwala M; Xing C; Schoggins JW; Alto NM Nature; 2019 Apr; 568(7751):249-253. PubMed ID: 30894749 [TBL] [Abstract][Full Text] [Related]
38. Inducible tumor necrosis factor (TNF) receptor-associated factor-1 expression couples the canonical to the non-canonical NF-κB pathway in TNF stimulation. Choudhary S; Kalita M; Fang L; Patel KV; Tian B; Zhao Y; Edeh CB; Brasier AR J Biol Chem; 2013 May; 288(20):14612-14623. PubMed ID: 23543740 [TBL] [Abstract][Full Text] [Related]
39. SM22α suppresses cytokine-induced inflammation and the transcription of NF-κB inducing kinase (Nik) by modulating SRF transcriptional activity in vascular smooth muscle cells. Dai X; Thiagarajan D; Fang J; Shen J; Annam NP; Yang Z; Jiang H; Ju D; Xie Y; Zhang K; Tseng YY; Yang Z; Rishi AK; Li HJ; Yang M; Li L PLoS One; 2017; 12(12):e0190191. PubMed ID: 29284006 [TBL] [Abstract][Full Text] [Related]
40. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs. Mukherjee T; Chatterjee B; Dhar A; Bais SS; Chawla M; Roy P; George A; Bal V; Rath S; Basak S EMBO J; 2017 Dec; 36(23):3501-3516. PubMed ID: 29061763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]